TY - JOUR
T1 - Altered peptide ligand design
T2 - Altering immune responses to class I MHC/peptide complexes
AU - Collins, Edward J.
AU - Frelinger, Jeffrey A.
PY - 1998/6
Y1 - 1998/6
N2 - Class I proteins are responsible for binding proteins from endogenously synthesized proteins and displaying them on the cell surface. Our understanding of this process has reached the point where we can manipulate the biochemical properties of peptide/class I binding and determine the effects of this alteration on subsequent immune responses. In this article, we will review the biochemistry of peptide/class I binding, and the effects of structure on this interaction between class I proteins and their peptide ligands. We will review the data which suggest that the major relevant biochemical parameter of class I peptide binding is the off-rate. We will show that the design of altered ligands with improved binding, thermostability and immunogenicity is possible.
AB - Class I proteins are responsible for binding proteins from endogenously synthesized proteins and displaying them on the cell surface. Our understanding of this process has reached the point where we can manipulate the biochemical properties of peptide/class I binding and determine the effects of this alteration on subsequent immune responses. In this article, we will review the biochemistry of peptide/class I binding, and the effects of structure on this interaction between class I proteins and their peptide ligands. We will review the data which suggest that the major relevant biochemical parameter of class I peptide binding is the off-rate. We will show that the design of altered ligands with improved binding, thermostability and immunogenicity is possible.
UR - http://www.scopus.com/inward/record.url?scp=0031819187&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031819187&partnerID=8YFLogxK
U2 - 10.1111/j.1600-065X.1998.tb01194.x
DO - 10.1111/j.1600-065X.1998.tb01194.x
M3 - Review article
C2 - 9700508
AN - SCOPUS:0031819187
SN - 0105-2896
VL - 163
SP - 151
EP - 160
JO - Immunological Reviews
JF - Immunological Reviews
ER -